CSNK1E and breast carcinoma: As the initial RNAi screens were limited to three β-catenin-positive lines and one β-catenin-negative line, we tested the hypothesis that CSNK1E is preferentially required in additional β-catenin-positive cells by determining the effects of its suppression in an expanded panel of breast cancer cell lines.